Abstract
Patients with multiple myeloma have a clonal proliferation of malignant plasma cells, each with an identical rearrangement of immunogloblin heavy and light chain genes. When these unique sequences are determined, a valuable molecular tool is available that can been used to detect the presence of the malignant population. Previous methods have employed oligonucleotides derived from these sequences and allele-specific polymeraes chain reaction to detect clonality. The method described in this chapter uses mRNA in situ hybridization (ISH) to demonstrate the presence of individual malignant cells. Single-cell analysis using mRNA ISH provides opportunities that when combined with immunophenotyping offer a valuable new investigative tool.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pope B., Brown R., Gibson J., and Joshua D. (1997) Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal. Bone Marrow Transplant. 20, 205ā210.
Ralph Q. M., Brisco M. J., Joshua D. E., Brown R., Gibson J., and Morley A. (1993) Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B cell clone: evidence from the Ig heavy chain gene. Blood 82, 202ā206.
Swedin A., Lenhoff S., Olofsson T., Thuresson B., and Westin J. (1988) Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma. Br. J. Haematol. 103, 1145ā1151.
Brisco M. J., Tan L. W., Osborn A. M., and Morley A. A. (1990) Development of a highly sensitive assay based on the polymerase chain reaction for rare B-lymphocyte clones in a polyclonal population. Br. J. Haematol. 75, 163ā167.
Lawrence J. B. and Singer R. H. (1985) Quantitative analysis of in situ hybridization methods for the detection of actin gene expression. Nucleic Acids Res. 13, 1777ā1799.
Gee C. E. and Roberts J. L. (1983) In situ hybridisation histochemistry: a technique for the study of gene expression in single cells. DNA 2, 157ā171.
Pringle J. H., Primose L., Kind C. N., Talbot I. C., and Lauder I. (1989) In situ hybridization demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections using a biotinylated oligonucleotide poly d(T) probe. J. Pathol. 158, 279ā286.
Markovic B., Kwan Y.-L., Nicholls E. M., Walsh C., and Crouch R. L. (1992) A sensitive method for the detection of poly-A tails of mRNA using a biotin labelled heteropolymer of dT:rA. J. Pathol. 167, 369ā373.
Brown R. D., Luo X.-F., Gibson J., et al. (1995) Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br. J. Haematol. 90, 113ā118.
Joshua D. E., Brown R. D., Luo X.-F., and Gibson J. (1996) Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization. Blood 88, 1125.
Sambrook J., Fritsch E. E., and Maniatas T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Kessler C. (1990) The digoxigenin system: principle and applications of the novel nonradioactive DNA labelling and detection system. Bio Technol. Int. 1990, 183ā194.
Hotlke H. J. and Kessler C. (1990) Non-radioactive labelling of RNA transcripts in vitro with the hapten digoxigenin (DIG): hybridization and ELISA-based detection. Nucleic Acids Res. 18, 5843ā5851.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Brown, R.D., Ho, P.J. (2005). Identification of Malignant Plasma Cells by mRNA In Situ Hybridization. In: Brown, R.D., Ho, P.J. (eds) Multiple Myeloma. Methods in Molecular Medicineā¢, vol 113. Humana Press. https://doi.org/10.1385/1-59259-916-8:175
Download citation
DOI: https://doi.org/10.1385/1-59259-916-8:175
Publisher Name: Humana Press
Print ISBN: 978-1-58829-392-3
Online ISBN: 978-1-59259-916-5
eBook Packages: Springer Protocols